CLONIDINE HYDROCHLORIDE

Post-LOE

clonidine hydrochloride

Hikma

ANDAINJECTIONINJECTABLE

Approved

Jan 2011

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CLONIDINE HYDROCHLORIDE (clonidine hydrochloride) by Hikma is mechanism of action epidurally administered clonidine produces dose-dependent analgesia not antagonized by opiate antagonists. Approved for combination with opiates for the treatment of severe pain in cancer patients. First approved in 2011.

Drug data last refreshed 19h ago

Mechanism of Action

Mechanism of Action Epidurally administered clonidine produces dose-dependent analgesia not antagonized by opiate antagonists. The analgesia is limited to the body regions innervated by the spinal segments where analgesic concentrations of clonidine are present. Clonidine is thought to produce…

Indications (1)

combination with opiates for the treatment of severe pain in cancer patients

Company

Worked on CLONIDINE HYDROCHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.